Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Epidemiology, Lymphomas, non-Hodgkin lymphoma, Workforce, Health Outcomes Research, Diseases, Real World Evidence, aggressive lymphoma, Registries, Lymphoid Malignancies
Type: Oral
Hematology Disease Topics & Pathways:
Epidemiology, Lymphomas, non-Hodgkin lymphoma, Workforce, Health Outcomes Research, Diseases, Real World Evidence, aggressive lymphoma, Registries, Lymphoid Malignancies
Saturday, December 11, 2021: 9:30 AM-11:00 AM
Georgia Ballroom 1-3
(Georgia World Congress Center)
Moderators:
Oreofe O. Odejide, MD, MPH, Dana-Farber Cancer Institute
and
Toby A. Eyre, Oxford University Hospitals NHS Foundation Trust
Disclosures:
Eyre: Roche: Consultancy, Honoraria; Gilead/KITE: Honoraria, Other: Travel support for conferences, Research Funding, Speakers Bureau; Janssen: Honoraria; Abbvie: Consultancy, Honoraria, Other: Travel to conferences; AstraZeneca: Honoraria, Research Funding; Loxo Oncology: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees; Beigene: Honoraria, Research Funding; Incyte: Consultancy; Secura Bio: Consultancy, Honoraria.
This session will present and discuss high quality, clinically relevant population based DLBCL data
9:30 AM
9:45 AM
10:00 AM
10:15 AM
10:30 AM
10:45 AM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH